Delivery Order SPE2DB22D2007-SPE2DB25FJ4WH
- Not listed
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a ceiling value of $1,159.29. This firm fixed-price delivery order, which is set to be completed by August 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involved no...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $1,270.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,708.36 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count packages) on June 18, 2025, with completion targeted for June 20, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $15,518.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 20 mg on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for KERENDIA 20 MG tablets (30-count package) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4WHDelivery Order
The Defense Logistics Agency awarded a $1,014.95 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical supplies to support military healthcare programs worldwide. This delivery order for Kerendia, a medication used in the management of chronic kidney disease, exemplifies the company's role as a critical vendor for specialized pharmaceutical products across multiple therapeutic domains within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/11/25 |